Advertisement

Topics

Latest Cardiovascular disease (CVD) NewsRSS

13:52 EDT 21st September 2017 | BioPortfolio

pMD Advances CV Care through MedAxiom Partnership

Fast-growing, award-winning health care tech leader brings charge capture and information sharing innovations to nation’s top CV organizations. MedAxiom, the nation’s leading cardiovascular health care membership organization and performance community, is pleased to announce its corporate partnership with pMD to help advance value-based CV health ...

Don't fall for these 6 Internet myths about statins

CHICAGO, Sept. 21, 2017 /PRNewswire-USNewswire/ -- Thanks to mailings and websites that claim statin medications are harmful or unnecessary, many patients are confused about whether they should take them. That's unfortunate, because the medication not only helps prevent heart attacks and strokes but also lowers the chance of developing peripheral arterial disease, or PAD, in which the a...

FDA Releases Cefaly® for Acute Treatment of Migraine Attacks

NEW YORK, Sept. 21, 2017 /PRNewswire/ -- CEFALY Technology announces today that on Friday, September 15th, the U.S. Food and Drug Administration (FDA) released the use of a new Cefaly® medical device for the acute treatment of migraine, with or without aura, in patients 18 years of age or older. The Cefaly Acute® will allow migraine patients to use the device during a migraine attack; ...

FDA Advisory Committee Recommends Approval of REMICADE® for Treatment of Pediatric Ulcerative Colitis

HORSHAM, Pa., July 21, 2011 /PRNewswire/ -- Janssen Biotech, Inc., formerly Centocor Ortho Biotech Inc., announced today that the Gastrointestinal Drugs Advisory Committee (GIDAC) of the U.S. Food and Drug Administration (FDA) recommended the approval of REMICADE® (infliximab) for the treatment of moderately to severely active ulcerative colitis (UC) in pediatric patients who have had an inad...

Leica Biosystems Celebrates 2,000 Global Digital Pathology Scanner Installations

VISTA, Calif., Sept. 21, 2017 /PRNewswire/ -- Leica Biosystems announced that it has delivered and installed its 2,000th digital pathology scanner. This is a key milestone for both the company and the digital pathology industry it pioneered. Leica Biosystems has been the digital pathology leader ever since it launched its first Aperio line scanners. "This is quite an achievement. By leve...

Vixiar Medical Taking up Residence at The LaunchPort™ in Port Covington

Cardiopulmonary Device Company Moves Headquarters to Baltimore Baltimore, MD (PRWEB) September 21, 2017 Vixiar Medical announced today that it will be moving its HQ office, which includes executive, engineering and manufacturing functions to The LaunchPort™ Accelerator at the City Garage in Port Covington. The LaunchPort™, and its affiliated operation The Factory™, provide a full range of m...

FDA Nod For ABMD, AERI Faces FDA Panel In Oct, IPCI Put On Notice, PFE Sues JNJ

Today's Daily Dose brings you news about Acceleron Pharma's public offering; pre-market approval of Abiomed's Impella RP heart pump; FDA panel review of Aerie's Rhopressa; NASDAQ notification for Intellipharmaceutics; positive data from Karyopharm's phase II/III SEAL study and Pfizer's suit against Johnson & Johnson.

Abiomed Receives FDA PMA Approval For Impella RP For Right Heart Failure

  Life Sciences Jobs   ...

Marshfield Clinic Demonstrates Improved Quality of Care Resulting in Cost Savings for Medicare

MARSHFIELD, Wis., Aug. 8, 2011 /PRNewswire/ -- When the Centers for Medicare & Medicaid Services (CMS) initiated its Physician Group Practice (PGP) Demonstration, it challenged the 10 participating large physician group practices to prove that providing high quality coordinated health care could also save money. CMS, part of the U.S. Department of Health and Human Services, announced today tha...

University Researchers Awarded Grant for Non-invasive System to Detect Atrial Fibrillation

Researchers at Rochester Institute of Technology and the University of Rochester Medical Center are developing a health app to incorporate into familiar technology such as a tablet or smartphone that will act as a clinical tool to assess atrial fibrillation, a growing heart ailment. Rochester, NY (PRWEB) September 20, 2017 Researchers are developing a health app to incorporate into familiar techn...

Dr. Srini Pillay, Acclaimed Author, Shares Three Counterintuitive Ways to Deal With a Painful Relationship

Srini Pillay, M.D., acclaimed author, speaks on a myriad of ways to manage a painful relationship. (PRWEB) September 20, 2017 Relationship challenges are not a new phenomenon, yet they continue to puzzle and confuse us. Acclaimed author, Srini Pillay, M.D., notes that people often make agreements to be related and proceed to compete for the status of "victim." "Each person feels li...

diaDexus, Inc. to Present at the Canaccord Genuity Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Dec. 5, 2011 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS), a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today said that it plans to present at the Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disord...

Top 5 Vendors in the Global Vascular Stents Market from 2017 to 2021: Technavio

Technavio has announced the top five leading vendors in their recent global vascular stents market 2017-2021 report. This market research report also lists 12 other prominent vendors that are expected to impact the market during the forecast period. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/ho...

An alternative to pacemakers? Ablation method treats sinus bradycardia

A new approach to treating symptomatic sinus bradycardia (SB) led to increased

Diagnostic Electrophysiology Devices Market - Segmentation Analysis and Forecasts by Technavio

According to the latest market study released by Technavio, the global diagnostic electrophysiology devices market is expected to grow at a CAGR of more than 7% through 2021. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170920005168/en/

Review suggests whole grains might not be as heart-healthy as we think

Primary Asset: Body:  We all know whole grains are our best dietary bet for staying healthy—right?One University of Warwick physician in the U.K. has suggested eating a diet rich in whole grains actually hasn’t been proven to be beneficial to heart health, Reuters reports. Karen Rees, PhD, recently published a research review in the Cochrane Library concluding any past experiments te...

Abbott's PA sensor system is clinically proven to work—but how safe is it?

Recent studies have proven Ab

Cellmid Ltd CDY Financial and Strategic SWOT Analysis Review [Report Updated: 07082017] Prices from USD $300

SummaryCellmid Ltd Cellmid, formerly Medical Therapies Limited develops therapies and diagnostic tests for inflammatory and fibrotic diseases, cancer, ischemic diseases of the heart, and hair loss. The company holds comprehensive portfolio of intellectual property relating to the novel targets midkine and FGF5. It offers products that include midkine ELISA kit, advangen international hair loss pr...

Preventice Solutions Receives Frost & Sullivan Award for Product Line Strategy Leadership in Remote Cardiac Monitoring

MINNEAPOLIS, Sept. 20, 2017 /PRNewswire/ -- Preventice Solutions announced today it received the 2017 Frost & Sullivan Product Line Strategy Leadership Award for its remote cardiac monitoring portfolio of technologies and services. Following an analysis of the remote cardiac monitoring industry in North America, Frost & Sullivan selected Preventice for the award based on the company's...

Global Angina Partnering 20102017 [Report Updated: 01092017] Prices from USD $1495

The Global Angina Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. Trends in partnering deals Top deals by value Deals listed by company AZ, industry sector, stage of development, technology typeThe report provides understanding and access to the partnering deals and agre...

Nature's Way® Launches New Turmerich™ Line of Targeted Turmeric Formulas

GREEN BAY, Wis., Sept. 20, 2017 /PRNewswire/ -- Nature's Way® Brands, LLC, one of the most recognized and trusted consumer dietary supplements brands, introduces Turmerich™, a new line of premium turmeric-based herbal products, formulated to address specific health needs. The line will initially offer two formulas: Turmerich Joint, for joint and mobility support*, and Turmerich Heart, for cardi...

Protect Your Kids This Flu Season

CINCINNATI, Dec. 5, 2011 /PRNewswire-USNewswire/ -- Doctors at Cincinnati Children's Hospital Medical Center want to make sure children are protected from influenza this flu season.  The flu is an infection of the nose, throat and lungs caused by a variety of strains of influenza viruses that circulate in communities every year. According to the web site Preventchildhoodinfluenza.org, i...

Frost & Sullivan Commends Omron Healthcare's Creation of its New Heat Pain Pro™ TENS Unit, the First Device on the Market that Combines Both Heat and Transcutaneous Electrical Nerve Stimulation (TENS)

SANTA CLARA, Calif., Sept. 20, 2017 /PRNewswire/ -- Based on its recent analysis of the home pain management industry, Frost & Sullivan recognizes Omron Healthcare, Inc. with the 2017 North America New Product Innovation Award. In line with the  growing awareness of the opioid epidemic, Omron Healthcare, Inc. (Omron) created its new Heat Pain Pro TENS Unit—the first device on the m...

Protagonist Therapeutics Announces Preliminary Phase 1 Study Results with Novel Hepcidin Mimetic, PTG-300

NEWARK, Calif., Sept. 20, 2017 /PRNewswire/ -- Protagonist Therapeutics, Inc. (Nasdaq: PTGX) today announced preliminary results from the Phase 1 study of PTG-300 in normal healthy volunteers. PTG-300 is an injectable hepcidin mimetic peptide, discovered using the company's proprietary technology platform. Protagonist is developing PTG-300 as a potential treatment for patients with ineffectiv...

“Stem Cell Therapy: A Rising Tide - How Stem Cells are Disrupting Medicine and Transforming Lives” - A New Book by Stem Cell Expert, Dr. Neil Riordan, Is On Sale Now

Neil H Riordan, author of MSC: Clinical Evidence Leading Medicine’s Next Frontier, the definitive textbook on clinical stem cell therapy, authors an easy-to-read book about what stem cells are, what they are not, how and why stem cells work, and why they’re the wave of the future. It provides fascinating insight into the therapeutic use of mesenchymal stem cells. Dallas-Fort Worth, Texas (PRWE...

Quick Search
Advertisement
 

review and buy Cardiovascular disease (CVD) market research data and corporate reports here